Cipla’s arm inks pact with Sri Lankan distributor

17 Jun 2014 Evaluate

Cipla’s wholly owned subsidiary, Cipla (Mauritius), has signed a definitive agreement with company’s existing Sri Lankan distributor for acquisition of 60% stake in a new company which will market the company’s products in Sri Lanka. The company has paid a consideration of $14 million for this transaction. However, the acquisition will be subject to regulatory approvals.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For more than 70 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries.

Cipla Share Price

1373.95 -10.85 (-0.78%)
09-May-2024 13:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1502.10
Dr. Reddys Lab 5920.40
Cipla 1373.95
Zydus Lifesciences 988.75
Lupin 1604.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.